Daihan PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Daihan PharmaceuticalLtd has a total shareholder equity of ₩268.3B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩313.4B and ₩45.0B respectively. Daihan PharmaceuticalLtd's EBIT is ₩37.2B making its interest coverage ratio -42.3. It has cash and short-term investments of ₩73.9B.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | -42.3x |
| Cash | ₩73.89b |
| Equity | ₩268.33b |
| Total liabilities | ₩45.02b |
| Total assets | ₩313.35b |
Recent financial health updates
Here's Why Daihan PharmaceuticalLtd (KOSDAQ:023910) Can Manage Its Debt Responsibly
Mar 02
Does Daihan PharmaceuticalLtd (KOSDAQ:023910) Have A Healthy Balance Sheet?
Nov 27Recent updates
Here's Why Daihan PharmaceuticalLtd (KOSDAQ:023910) Can Manage Its Debt Responsibly
Mar 02Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Feb 09
Can You Imagine How Daihan PharmaceuticalLtd's (KOSDAQ:023910) Shareholders Feel About The 34% Share Price Increase?
Jan 19What Kind Of Shareholders Hold The Majority In Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Shares?
Dec 18Does Daihan PharmaceuticalLtd (KOSDAQ:023910) Have A Healthy Balance Sheet?
Nov 27Financial Position Analysis
Short Term Liabilities: A023910's short term assets (₩132.5B) exceed its short term liabilities (₩38.3B).
Long Term Liabilities: A023910's short term assets (₩132.5B) exceed its long term liabilities (₩6.7B).
Debt to Equity History and Analysis
Debt Level: A023910 is debt free.
Reducing Debt: A023910 has no debt compared to 5 years ago when its debt to equity ratio was 18.6%.
Debt Coverage: A023910 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A023910 has no debt, therefore coverage of interest payments is not a concern.